All Technology

Core Technolog

Core Technolog

DETAIL
Our core technology centers around UMSC (allogeneic umbilical cord mesenchymal stem cell drug). These remarkable stem cells, derived from the youngest allogeneic tissues, are readily available off-the-shelf.

UMSCs exhibit a unique array of functions that make them exceptionally promising for therapeutic applications. Their versatility includes:

Proliferation and Differentiation: Utilizing a specialized culture approach, we stimulate the multiplication of stem cells and encourage their transformation into specific cell types, thereby maximizing their therapeutic capabilities.

Immunomodulation: UMSCs possess potent immunomodulatory properties, allowing them to modulate immune responses. This capability is particularly valuable in conditions involving inflammation and immune disorders.

Regenerative Potential: These stem cells have the remarkable ability to promote tissue regeneration and repair, making them ideal candidates for addressing various medical conditions, including tissue injuries and degenerative diseases.

Anti-Inflammatory Effects: UMSCs release anti-inflammatory factors that can reduce inflammation at the site of injury or disease, contributing to improved healing and reduced tissue damage.

Angiogenesis Promotion: They stimulate the formation of new blood vessels (angiogenesis), which can be crucial for restoring blood supply to damaged tissues.

Homotypic Migration: UMSCs have the capacity to migrate to specific target tissues and homing in on areas that require repair or regeneration.

Safety and Efficacy: Our phase I clinical trial not only validates the safety of our UMSC-based drug but also demonstrates its remarkable efficacy, offering new hope for patients with various medical conditions.

By harnessing the multifaceted functions of UMSCs, our core technology aims to revolutionize the field of regenerative medicine and provide innovative solutions to address unmet medical needs.